Xtract One Technologies Inc. sees a slight dip in stock price this week despite recent expansion news.
Xtract One Technologies Inc. (XTRA.TO) has had a mixed week on the TSX, closing down 3.28% on Friday but gaining 3.51% over the past week. The company’s recent developments in the pharmaceutical and life sciences sector have attracted investor attention, influencing the stock's performance.
Investor takeaway: Investors should consider how Xtract One's new deployments in pharmaceuticals could drive growth, while also monitoring its current technical indicators and market conditions.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Xtract One Technologies Inc.
XTRA.TO
XTRA.TO
Xtract One Technologies Inc.
WealthAwesomeMarket cap
$158.56M
52W high
$0.98
52W low
$0.33
1W change
+3.51%
Beta
1.39
Analyst Price Targets
Based on analyst covering XTRA
Wall Street analysts forecast XTRA stock price to rise 103.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.20
+103.4% Upside
Current Price
C$0.59
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on XTRA's historical volatility
30-Day Vol
93.4%
Annualized
90-Day Vol
71.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.71
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.63 | C$0.45 – C$0.86 |
| 60 trading days | C$0.66 | C$0.42 – C$1.05 |
| 90 trading days | C$0.71 | C$0.40 – C$1.23 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Xtract One Technologies Inc. has a market cap of approximately C$158.6 million.
With an average analyst target of C$1.20, there is a potential upside of 103.4% from its last close price of C$0.59, suggesting a positive outlook despite recent price fluctuations.
Bull case
The recent expansion into pharmaceutical and life sciences manufacturing could create new revenue opportunities for Xtract One, making it a potentially appealing investment as the company diversifies its offerings.
Bear case
Despite the positive developments, Xtract One's negative profit margins and declining year-to-date performance may raise concerns about its financial health and operational efficiency.
Price Action Overview
Xtract One Technologies Inc. closed at C$0.59 on Friday, marking a decline of 3.28% for the day. However, over the past week, the stock has gained 3.51%, indicating some volatility in response to market conditions and recent company news.
Company News Catalyst
On July 14, 2026, Xtract One Technologies announced further expansion into the pharmaceutical and life sciences manufacturing sector with a new multi-state deployment. This strategic move is expected to enhance the company’s market presence and diversify its revenue streams.
Technical Picture
Xtract One's stock is currently trading above its 50-day moving average of C$0.54, reflecting a positive trend of 8.7%. The 200-day moving average stands at C$0.58, showing a slight increase of 0.9% compared to the current price. The 52-week trading range for the stock has been between C$0.33 and C$0.98, indicating that the stock is currently trading at approximately 40% of its range. With a beta of 1.39, the stock is more volatile than the market, which may be a consideration for risk-averse investors.
Advertisement
